Biologics in Dermatology

Skin and subcutaneous diseases affect millions of people worldwide, causing significant morbidity. Biologics are becoming increasingly useful for the treatment of many skin diseases, particularly as alternatives for patients who have failed to tolerate or respond to conventional systemic therapies....

Descripción completa

Detalles Bibliográficos
Autores principales: Chandler, David, Bewley, Anthony
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2013
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3816698/
https://www.ncbi.nlm.nih.gov/pubmed/24276125
http://dx.doi.org/10.3390/ph6040557
_version_ 1782477975260758016
author Chandler, David
Bewley, Anthony
author_facet Chandler, David
Bewley, Anthony
author_sort Chandler, David
collection PubMed
description Skin and subcutaneous diseases affect millions of people worldwide, causing significant morbidity. Biologics are becoming increasingly useful for the treatment of many skin diseases, particularly as alternatives for patients who have failed to tolerate or respond to conventional systemic therapies. Biological therapies provide a targeted approach to treatment through interaction with specific components of the underlying immune and inflammatory disease processes. This review article examines the increasing evidence base for biologics in dermatology, including well-established treatments and novel agents.
format Online
Article
Text
id pubmed-3816698
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-38166982013-11-14 Biologics in Dermatology Chandler, David Bewley, Anthony Pharmaceuticals (Basel) Review Skin and subcutaneous diseases affect millions of people worldwide, causing significant morbidity. Biologics are becoming increasingly useful for the treatment of many skin diseases, particularly as alternatives for patients who have failed to tolerate or respond to conventional systemic therapies. Biological therapies provide a targeted approach to treatment through interaction with specific components of the underlying immune and inflammatory disease processes. This review article examines the increasing evidence base for biologics in dermatology, including well-established treatments and novel agents. MDPI 2013-04-17 /pmc/articles/PMC3816698/ /pubmed/24276125 http://dx.doi.org/10.3390/ph6040557 Text en © 2013 by the authors; licensee MDPI, Basel, Switzerland. http://creativecommons.org/licenses/by/3.0/ This article is an open-access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/3.0/).
spellingShingle Review
Chandler, David
Bewley, Anthony
Biologics in Dermatology
title Biologics in Dermatology
title_full Biologics in Dermatology
title_fullStr Biologics in Dermatology
title_full_unstemmed Biologics in Dermatology
title_short Biologics in Dermatology
title_sort biologics in dermatology
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3816698/
https://www.ncbi.nlm.nih.gov/pubmed/24276125
http://dx.doi.org/10.3390/ph6040557
work_keys_str_mv AT chandlerdavid biologicsindermatology
AT bewleyanthony biologicsindermatology

Ejemplares similares